By employing hiPSC technology for modeling AGS1, AGS2, and AGS7, they established an innovative in vitro model of AGS, useful to investigate mechanisms of drugs potentially effective in these pathologies (Table 1). The gene discussed is TREX1; the disease is Aicardi-Goutieres syndrome.